Highlights Merck KGaA

Stocks

MRK

DE0006599905

Pharmaceuticals

Market Closed - Xetra Other stock markets 09:05:01 15/06/2026 pm IST			After hours 11:37:10 pm
132.70 ^EUR	-0.41%		132.62	-0.06%

09/06	Merck Announces Management Appointments	CI
01/06	MERCK KGAA : Receives a Buy rating from JP Morgan	ZD

Highlights

09/06	Merck Announces Management Appointments	CI
21/05	Merck KGaA, Darmstadt, Germany Announces First Patient Dosed In Phase 3 Study For Investigational Antibody-Drug Conjugate In Colorectal Cancer	CI
19/05	Merck KGaA: From 19th-century cocaine to tomorrow's AI chips
19/05	Bernstein Expects Merck KGaA ROIC to Outpace WACC Earlier; Price Target, Estimates Up	MT
13/05	Merck KGaA Update Earnings Guidance for the Fiscal Year 2026	CI
13/05	Merck: An upgrade in Q1 signals high confidence
13/05	Merck raises annual guidance after unexpectedly strong start - Shares top DAX	DP
13/05	Germany's Merck KGaA Shares Jump After Guidance Lift	DJ
13/05	Merck KGaA Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
13/05	Merck raises outlook as pharma supplies and AI boom provide tailwinds	RE
13/05	Merck KGaA Upgrades FY26 Sales Outlook; Midterm Outlook Affirmed	MT
13/05	Germany's Merck KGaA Raises Guidance	DJ
13/05	Merck KGaA's Q1 Profit, Net Sales Decline	MT
13/05	Merck KGaA lifts 2026 profit outlook on demand for lab supplies	RE
07/05	Merck Kgaa Becomes Sole Testing Provider for Genetix Biotherapeutics' Fda-Approved Gene Therapies	CI
07/05	Genetix Selects Merck KGaA as Sole Testing Provider for Gene Therapies	MT
07/05	Merck and Genetix Biotherapeutics Enter Five-Year Agreement for Analytical and Biosafety Release Testing Services	CI
05/05	Merck KGaA Opens New French Site to Boost Metrology, Inspection Tools Production	MT
30/04	Merck Kgaa, Darmstadt, Germany Announces First Dose in Phase 3 Study with Enpatoran for Lupus Patients with Active Skin Manifestations	CI
29/04	BofA Expects Merck KGaA's Q1 EBITDA to Beat Consensus; Buy Rating Kept	MT
28/04	Remepy and Merck KGaA, Darmstadt Germany Collaborate to Advance Hybrid Drugs Across Therapeutic Areas	CI
27/04	For final dividend	FA
21/04	Merck Launches First Bio-Based Solvent Portfolio for High-Performance Liquid Chromatography	CI
16/04	Merck KGaA Price Target, Forecasts Cut as AlphaValue/Baader Europe Notes 'Restrained' Growth Prospects	MT
16/04	Merck: Pharma business’s reinvigoration remains key for re-rating